Search Results 861-870 of 17262 for monoclonal antibody

1. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

   Prior antibody treatment for cancer must have been ... Sacituzumab govitecan-hziy is an antibody-drug conjugate that combines a humanized monoclonal ...

2. Clinical trials - Oncology (Medical)

   This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

3. Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients - Mayo Clinic

   Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) ...

4. Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma - Mayo Clinic

   Participation eligibility · Received any prior monoclonal antibody against CTLA-4, programmed cell death 1 (PD1) or programmed cell death 1 ligand 1 (PD-L1); ...

5. Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 - Mayo Clinic

   infusion reaction or hypersensitivity (CTCAE Grade 3 or higher) with monoclonal antibody treatment - Clinically significant cardiac disease, including but ...

6. A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab - Mayo Clinic

   ... antibody, avelumab, in selected advanced solid tumors. ... Known prior severe hypersensitivity reaction to monoclonal antibodies (grade ≥ 3 by NCI CTCAE v4.

7. Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

   - History of severe hypersensitivity to another monoclonal antibody - Other concurrent cancer or a history of another invasive malignancy within the last 3

8. Palivizumab (intramuscular route) - Side effects & uses - Mayo Clinic

   It belongs to a group of medicines known as immunizing agents. This medicine works by giving your body antibodies to protect it against RSV infection. RSV ...

9. Integration, innovation, precision: Propelling leading-edge diagnostics - Mayo Clinic News Network

   At present, of the 30-plus antibodies the neuroimmunology lab has tests for, more than five are only available at Mayo Clinic Laboratories because they are new ...

10. Medical Research & Education - Mayo Clinic News Network

    Latest stories · Mayo Clinic expert answers questions about antibody testing for COVID-19 featured image · Mayo Clinic Q&A podcast: COVID-19 research task force ...